Bedside to bench and back again-translational research in interventional pulmonology.
Iqbal B. et al, (2024), Current opinion in pulmonary medicine
PneumoLLM: Harnessing the power of large language model for pneumoconiosis diagnosis.
Song M. et al, (2024), Medical image analysis, 97
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity
Hamid MHBA. et al, (2024), Nature Immunology, 25, 834 - 846
Clinical identification of malignant pleural effusions.
Jia J. et al, (2023), Translational oncology, 39
Achieving Molecular Profiling in Pleural Biopsies
Sundaralingam A. et al, (2023), Chest, 163, 1328 - 1339
Reply to Yasuma et al.
Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 950 - 950
The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study
Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 731 - 739
Malignant pleural effusion: Updates in diagnosis, management and current challenges
Addala DN. et al, (2022), Frontiers in Oncology, 12
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
Evans RA. et al, (2022), The Lancet Respiratory Medicine, 10, 761 - 775
The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing
Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302
Objective Thoracoscopic Criteria in Differentiation between Benign and Malignant Pleural Effusions
Ellayeh M. et al, (2022), Respiration, 101, 46 - 56
The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma
Asciak R. et al, (2021), Chest, 160, 1925 - 1933
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation
Asciak R. et al, (2021), Frontiers in Oncology, 11
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Guariglia A. et al, (2020), Breathe (Sheffield, England), 16
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments
Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008
Osteopontin drives KRAS-mutant lung adenocarcinoma
Giopanou I. et al, (2020), Carcinogenesis, 41, 1134 - 1144
Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set
Mercer RM. et al, (2020), Respirology, 25, 750 - 755
Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice
Bedawi EO. et al, (2020), European Respiratory Journal, 55, 1902245 - 1902245